Epidemiological evidence for the STI prevention effectiveness of female condoms
| Author | Year | Study population | No | Design | Outcomes | Key findings | |||
|---|---|---|---|---|---|---|---|---|---|
| Soper et al8 | 1993 | Gynaecology clinic patients with trichomoniasis (United States) | 104 | Prospective cohort | Trichomoniasis | No compliant female condom users re-infected v 14% of women not given female condoms and 14.7% of non-compliant users (p = 0.08). | |||
| Fontanet et al9 | 1998 | Sex workers in commercial sex establishments (Thailand) | 548 | Randomised controlled trial | Chlamydia, gonorrhoea, trichomoniasis, genital ulcer disease | Any STI: RR = 0.76 (95% CI: 0.50 to 1.16) Reduction in STIs in 1 of 4 sites: RR = 0.47 (95% CI: 0.25 to 0.91) | |||
| Feldblum et al11 | 2001 | Women in six matched community pairs (Kenya) | 1752 | Community randomised controlled trial | Chlamydia, gonorrhoea, trichomoniasis | Any STI: OR = 1.1 (95% CI: 0.8 to 1.6) | |||
| French et al10 | 2003 | Women seen at STD clinic (United States) | 1442 | Randomised controlled trial | Chlamydia, gonorrhoea, trichomoniasis, syphilis | Any STI, comparing female + male condoms to male condom alone: RR = 0.79 (95% CI: 0.59 to 1.06) |